User profiles for David Friedecký

David Friedecký

Professor of Medical Chemistry and Bichemistry, Palacky University Olomouc
Verified email at upol.cz
Cited by 1704

[HTML][HTML] Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status

…, L Tučková, E Hényková, M Strnad, D Friedecký… - Biomedicines, 2022 - mdpi.com
The understanding of neurodegenerative diseases, traditionally considered to be well-defined
entities with distinguishable clinical phenotypes, has undergone a major shift over the last …

[HTML][HTML] Lipidomic profiling of human serum enables detection of pancreatic cancer

…, R Ahrends, R Brumarová, D Friedecký… - Nature …, 2022 - nature.com
Pancreatic cancer has the worst prognosis among all cancers. Cancer screening of body
fluids may improve the survival time prognosis of patients, who are often diagnosed too late at …

[HTML][HTML] Clinical lipidomics in the era of the big data

…, B Piskláková, E Ivanovová, D Friedecký - Clinical Chemistry and …, 2023 - degruyter.com
Lipidomics as a branch of metabolomics provides unique information on the complex lipid
profile in biological materials. In clinically focused studies, hundreds of lipids together with …

High‐throughput capillary electrophoretic method for determination of total aminothiols in plasma and urine

P Lochman, T Adam, D Friedecký, E Hlídková… - …, 2003 - Wiley Online Library
Increased interest in the analysis of aminothiols in body fluids during the last years results in
a request for high‐throughput analytical methods for their determination. We report here a …

[HTML][HTML] Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse model

…, G Fricker, KM Kanninen, T Malm, D Friedecký… - Neuroscience, 2022 - Elsevier
Neuroinflammation is an important feature in the pathogenesis and progression of central
nervous system (CNS) diseases including Alzheimer’s disease (AD). One of the widely used …

[PDF][PDF] Lapatinib in breast cancer-the predictive significance of HER1 (EGFR), HER2, PTEN and PIK3CA genes and lapatinib plasma level assessment

…, K Cwiertka, R Trojanec, D Friedecky… - Biomed Pap Med …, 2010 - biomed.papers.upol.cz
Background. Breast cancer treatment trends are currently based on tailored therapies using
tumor and patient biomarkers. Lapatinib is the first dual inhibitor of HER1 (EGFR, ErbB1) …

Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders

…, E Hlídková, A Barešová, D Friedecký… - … of Chromatography A, 2012 - Elsevier
Metabolomics has become an important tool in clinical research and diagnosis of human
diseases. In this work we focused on the diagnosis of inherited metabolic disorders (IMDs) in …

[HTML][HTML] From big data to better patient outcomes

T Hulsen, D Friedecký, H Renz, E Melis… - Clinical Chemistry and …, 2023 - degruyter.com
Among medical specialties, laboratory medicine is the largest producer of structured data
and must play a crucial role for the efficient and safe implementation of big data and artificial …

[HTML][HTML] Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

A Kvasnička, D Friedecký, R Brumarová… - Arthritis Research & …, 2023 - Springer
Background Currently, it is not possible to predict whether patients with hyperuricemia (HUA)
will develop gout and how this progression may be affected by urate-lowering treatment (…

Oxidized phosphatidylcholines suggest oxidative stress in patients with medium-chain acyl-CoA dehydrogenase deficiency

L Najdekr, A Gardlo, L Mádrová, D Friedecký… - Talanta, 2015 - Elsevier
Inborn errors of metabolism encompass a large group of diseases caused by enzyme
deficiencies and are therefore amenable to metabolomics investigations. Medium chain acyl-CoA …